FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1921836145> ?p ?o ?g. }

• W1921836145 endingPage "7469" @default.
• W1921836145 startingPage "7454" @default.
• W1921836145 abstract "// Jiali Zhang 1, 2, * , Yu Wang 1, 2 * , Xinming Chen 1, 2 , Yi Zhou 1 , Fangyan Jiang 1 , Jirong Chen 1 , Li Wang 1 , Wen-Feng Zhang 1 1 The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei_MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, China 2 Oral Histopathology Department, School and Hospital of Stomatology, Wuhan University, Wuhan, China * These authors have contributed equally to this work Correspondence to: Jiali Zhang, e-mail: jiali_zhang97@163.com Xinming Chen, e-mail: xmchen3011@163.com Wen-Feng Zhang, e-mail: zhangwf59@163.com Keywords: Head and neck squamous cell carcinoma, miR-34a, amphiregulin, metastasis Received: August 11, 2014      Accepted: January 16, 2015      Published: February 05, 2015 ABSTRACT MiR-34a is a well-known tumor metastasis inhibitor, but only a few target genes involved in metastasis have been identified. In HNSCC, the role of miR-34a in metastasis has not been fully elaborated, and the target gene of miR-34a is still blind. Here we addressed that, the relative lower expression of miR-34a is associated with HNSCC lymphatic metastasis. HNSCC metastasis was found to be strongly suppressed in vitro and in vivo by over-expressing miR-34a. In order to screen the possible target genes of miR-34a in HNSCC, a microarray-based differential mRNA profiling mediated by miR-34a over-expression was performed, and AREG was identified as a pivotal target. We demonstrated that the mRNA and protein levels of AREG were greatly reduced when forcing miR-34a expression. The correlation between AREG mRNA levels and HNSCC metastatic phenotype was also significant in HNSCC tissues ( p < 0.01). Moreover, the results of luciferase assay provided the further evidence that miR-34a degraded AREG mRNA through targeting the 3’-UTR site. Restoration of AREG expression partially rescued miR-34a-mediated cell invasion defects in vivo and in vitro . Additionally, Over-expressing miR-34a greatly reduced EGFR and uPA, which were reversed by re-expression of AREG. Taken together, these findings indicate that miR-34a targets AREG, and is essential in inhibition of HNSCC metastasis." @default.
• W1921836145 created "2016-06-24" @default.
• W1921836145 creator A5012278873 @default.
• W1921836145 creator A5020920311 @default.
• W1921836145 creator A5021376476 @default.
• W1921836145 creator A5058784234 @default.
• W1921836145 creator A5074385560 @default.
• W1921836145 creator A5077863311 @default.
• W1921836145 creator A5085148532 @default.
• W1921836145 creator A5091841028 @default.
• W1921836145 date "2015-02-05" @default.
• W1921836145 modified "2023-10-11" @default.
• W1921836145 title "MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC)" @default.
• W1921836145 cites W1480344559 @default.
• W1921836145 cites W1502740750 @default.
• W1921836145 cites W1527111349 @default.
• W1921836145 cites W1600624515 @default.
• W1921836145 cites W16349381 @default.
• W1921836145 cites W1964321121 @default.
• W1921836145 cites W1972409452 @default.
• W1921836145 cites W1991674206 @default.
• W1921836145 cites W1995242599 @default.
• W1921836145 cites W1995702599 @default.
• W1921836145 cites W1997691220 @default.
• W1921836145 cites W2001298273 @default.
• W1921836145 cites W2002885378 @default.
• W1921836145 cites W2018056175 @default.
• W1921836145 cites W2020143753 @default.
• W1921836145 cites W2022366125 @default.
• W1921836145 cites W2023188630 @default.
• W1921836145 cites W2026743084 @default.
• W1921836145 cites W2027678100 @default.
• W1921836145 cites W2036033314 @default.
• W1921836145 cites W2037505934 @default.
• W1921836145 cites W2037602535 @default.
• W1921836145 cites W2040587084 @default.
• W1921836145 cites W2041714373 @default.
• W1921836145 cites W2051183427 @default.
• W1921836145 cites W2055149726 @default.
• W1921836145 cites W2055588547 @default.
• W1921836145 cites W2063508984 @default.
• W1921836145 cites W2069266255 @default.
• W1921836145 cites W2069769158 @default.
• W1921836145 cites W2070990294 @default.
• W1921836145 cites W2074210527 @default.
• W1921836145 cites W2081091619 @default.
• W1921836145 cites W2087397570 @default.
• W1921836145 cites W2093364931 @default.
• W1921836145 cites W2095648496 @default.
• W1921836145 cites W2097180978 @default.
• W1921836145 cites W2101057168 @default.
• W1921836145 cites W2107561954 @default.
• W1921836145 cites W2111129864 @default.
• W1921836145 cites W2116886958 @default.
• W1921836145 cites W2123206362 @default.
• W1921836145 cites W2124006359 @default.
• W1921836145 cites W2128574297 @default.
• W1921836145 cites W2131011594 @default.
• W1921836145 cites W2134406194 @default.
• W1921836145 cites W2139992910 @default.
• W1921836145 cites W2140473883 @default.
• W1921836145 cites W2141156902 @default.
• W1921836145 cites W2142574624 @default.
• W1921836145 cites W2144154026 @default.
• W1921836145 cites W2148453050 @default.
• W1921836145 cites W2149385130 @default.
• W1921836145 cites W2152035403 @default.
• W1921836145 cites W2155487079 @default.
• W1921836145 cites W2157640699 @default.
• W1921836145 cites W2158089750 @default.
• W1921836145 cites W2159461048 @default.
• W1921836145 cites W2161084369 @default.
• W1921836145 cites W2165948908 @default.
• W1921836145 cites W2166946831 @default.
• W1921836145 cites W2170685293 @default.
• W1921836145 cites W4211162417 @default.
• W1921836145 doi "https://doi.org/10.18632/oncotarget.3148" @default.
• W1921836145 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4480692" @default.
• W1921836145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25762634" @default.
• W1921836145 hasPublicationYear "2015" @default.
• W1921836145 type Work @default.
• W1921836145 sameAs 1921836145 @default.
• W1921836145 citedByCount "20" @default.
• W1921836145 countsByYear W19218361452016 @default.
• W1921836145 countsByYear W19218361452017 @default.
• W1921836145 countsByYear W19218361452018 @default.
• W1921836145 countsByYear W19218361452019 @default.
• W1921836145 countsByYear W19218361452020 @default.
• W1921836145 countsByYear W19218361452021 @default.
• W1921836145 countsByYear W19218361452022 @default.
• W1921836145 countsByYear W19218361452023 @default.
• W1921836145 crossrefType "journal-article" @default.
• W1921836145 hasAuthorship W1921836145A5012278873 @default.
• W1921836145 hasAuthorship W1921836145A5020920311 @default.
• W1921836145 hasAuthorship W1921836145A5021376476 @default.
• W1921836145 hasAuthorship W1921836145A5058784234 @default.
• W1921836145 hasAuthorship W1921836145A5074385560 @default.
• W1921836145 hasAuthorship W1921836145A5077863311 @default.

• next